As of 2025-07-15, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -96.65 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 207.50 GBP, the upside of Faron Pharmaceuticals Oy is -146.58%.
Based on its market price of 207.50 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 146.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -96.65 - -96.65 | -96.65 | -146.58% |
| P/E | (171.26) - (97.42) | (225.67) | -208.8% |
| DDM - Stable | (150.10) - (575.96) | (363.03) | -275.0% |
| DDM - Multi | (78.09) - (244.99) | (119.86) | -157.8% |
| Market Cap (mil) | 241.10 |
| Beta | 0.16 |
| Outstanding shares (mil) | 1.16 |
| Enterprise Value (mil) | 243.36 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.02% |
| Cost of Debt | 5.00% |
| WACC | 9.81% |